Lee A. Hebert
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lee A. Hebert has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Dan N. Spetie
Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA
3 shared publicationsGarima Agarwal
Departments of Internal Medicine, Pathology, Radiology, and Statistics, The Ohio State University, Columbus, OH
2 shared publicationsGyongyi Nadasdy
Departments of Internal Medicine, Pathology, Radiology, and Statistics, The Ohio State University, Columbus, OH
2 shared publicationsTibor Nadasdy
Departments of Internal Medicine, Pathology, Radiology, and Statistics, The Ohio State University, Columbus, OH
2 shared publicationsAndrew Levey
New England Medical Center, Boston, MA, USA
1 shared publicationAnil K. Agarwal
Departments of Internal Medicine, Pathology, Radiology, and Statistics, The Ohio State University, Columbus, OH
1 shared publication
Latest Publications
- 1 March 2006
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 47 (3) , 419-427
Proposed Pathogenesis of Idiopathic Loin Pain–Hematuria Syndrome
- 1 March 2006
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 47 (3) , 419-427
Proposed Pathogenesis of Idiopathic Loin Pain–Hematuria Syndrome
- 1 December 2004
- Published by Elsevier in Kidney International
- Vol. 66 (6) , 2411-2415
Mycophenolate therapy of SLE membranous nephropathy
- 1 December 2004
- Published by Elsevier in Kidney International
- Vol. 66 (6) , 2411-2415
Mycophenolate therapy of SLE membranous nephropathy
- 1 March 2004
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 43 (3) , e10.1-e10.4
Mycophenolate therapy in frequently relapsing minimal change disease that has failed cyclophosphamide therapy
- 1 March 2004
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 43 (3) , e10.1-e10.4
Mycophenolate therapy in frequently relapsing minimal change disease that has failed cyclophosphamide therapy
- 1 May 2003
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 41 (5) , 962-971
High urine volume and low urine osmolality are risk factors for faster progression of renal disease
- 1 May 2003
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 41 (5) , 962-971
High urine volume and low urine osmolality are risk factors for faster progression of renal disease
- 1 January 2003
- Published by S. Karger AG in Nephron Clinical Practice
- Vol. 93 (1) , c7-c12
Management of Lupus Nephropathy
This review is an evidence- and experience-based approach to the management of SLE, particularly its kidney manifestations. Specific protocols in substantial clinical detail are provided for management and monitoring, according to the severity of the SLE manifestations. The protocols are adapted from those used in a major SLE trial. The adaptations are based on subsequent extensive clinical use of these protocols. Also described is the concomitant use of cardio- and kidney-protective therapies to optimize patient outcomes.
- 1 January 2003
- Published by S. Karger AG in Nephron Clinical Practice
- Vol. 93 (1) , c7-c12
Management of Lupus Nephropathy
This review is an evidence- and experience-based approach to the management of SLE, particularly its kidney manifestations. Specific protocols in substantial clinical detail are provided for management and monitoring, according to the severity of the SLE manifestations. The protocols are adapted from those used in a major SLE trial. The adaptations are based on subsequent extensive clinical use of these protocols. Also described is the concomitant use of cardio- and kidney-protective therapies to optimize patient outcomes.
- 1 October 2001
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 110 (4) , 79-96
The urgent call of albuminuria/proteinuria
Microalbuminuria, one of the earliest indicators of kidney injury, could be a harbinger of progressive kidney failure. Similarly, it can also be one of the early signs that a patient at risk for cardiovascular disease is in fact developing the disease. If so, the patient's therapy is failing. Discussion of specific appropriate interventions are beyond the scope of this article. However, publications referred to in this work have recently discussed such interventions in substantial practical detail. Ample evidence shows that factors that are kidney-protective are also cardiovascular-protective.
- 1 October 2001
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 110 (4) , 79-96
The urgent call of albuminuria/proteinuria
Microalbuminuria, one of the earliest indicators of kidney injury, could be a harbinger of progressive kidney failure. Similarly, it can also be one of the early signs that a patient at risk for cardiovascular disease is in fact developing the disease. If so, the patient's therapy is failing. Discussion of specific appropriate interventions are beyond the scope of this article. However, publications referred to in this work have recently discussed such interventions in substantial practical detail. Ample evidence shows that factors that are kidney-protective are also cardiovascular-protective.